Conversely, the IL-6 levels in the MS group exhibited a decreasing trend in the LEP compared to in the HEP (54.47 ± 24.75 pg/mL vs. 41.94 ± 20.54 pg/mL, p = 0.059). This evidence concerns the gene IL6 and myeloid sarcoma.